Pathology & Laboratory
Medicine Grand Rounds 2021
Webcasts
Sarcoma Genomics: Does Advancing Science Also Advance Patient Care?
Release date: August 24, 2021
Expiration date: August 24, 2023
Estimated Time of Completion: 1 hour
Description
Pathology & Laboratory Medicine Grand Rounds 2021 CME-certified webcast series features presentations from the Pathology & Laboratory Medicine Institute Grand Rounds. Faculty provide evidence-based guidance on the diagnosis and management of challenging cases in prostate disease, renal neoplasms, GI, hepatobiliary/ pancreatic, endometrial and uterine masses, pancreatic and lung cytology, bone and soft tissue lesions and pulmonary pathology.
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest: Alexander Lazar, MD: Abbvie Pharmaceuticals - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). ArcherDx - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Astra Zeneca - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). BMS - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Bayer - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Beta-Cat Pharmaceuticals - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Elsevier - Board Membership, Consulting, Intellectual property rights (Royalties or patent sales), Membership on advisory committee or review panels , Ownership interest (stock, stock options). Flagship Pioneering - Board Membership, Consulting, Intellectual property rights (Royalties or patent sales), Membership on advisory committee or review panels , Ownership interest (stock, stock options). Foghorn Therapeutics - Board Membership, Consulting, Intellectual property rights (Royalties or patent sales), Membership on advisory committee or review panels , Ownership interest (stock, stock options). Foghorn Therapeutics, Flagship Pioneering, Human Longevity Inc, Nucleai, Elsevier, SpringerNature, USCAP, CAP, AACR, ASCO, WHO / IARC, various VC, strategic consultancies, & marketing concerns - Board Membership, Consulting, Intellectual property rights (Royalties or patent sales), Membership on advisory committee or review panels , Ownership interest (stock, stock options). GSK - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). GSK, Novartis, BMS, Pfizer, Loxo / Bayer, AbbVie, Astra-Zeneca / MedImmune, Merck, Roche / Genentech / Ignyta, ArcherDx, Illumina, ThermoFisher, Beta-Cat Pharmaceuticals / Iterion Therapeutics, - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Genentech/Roche - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Human Longevity, Inc. - Board Membership, Consulting, Intellectual property rights (Royalties or patent sales), Membership on advisory committee or review panels , Ownership interest (stock, stock options). Ignyta - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Illumina, Inc. - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Iterion Therapeutics - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). LOXO Pharmaceuticals - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Medimmune - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Merck - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Novartis - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Nucleai - Board Membership, Consulting, Intellectual property rights (Royalties or patent sales), Membership on advisory committee or review panels , Ownership interest (stock, stock options). Pfizer - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). SpringerNature - Board Membership, Consulting, Intellectual property rights (Royalties or patent sales), Membership on advisory committee or review panels , Ownership interest (stock, stock options). Thermo Fisher Scientific Inc., - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Deciphera Pharmaceuticals - Research / Independent Contractor, Membership on advisory committee or review panels .
The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest: Steven Billings, MD, Deborah Chute, MD, Gary W Procop, MD, Caroline Astbury, PhD, Michael Cruise, MD, Amy S JoehlinPrice, MD, Jennifer S Ko, MD, Jesse Mckenney, MD, Adam McShane, PhD, Megan Nakashima, MD, Sarah Ondrejka, DO, Christopher Przybycin, MD, Jordan Reynolds, MD, Gloria Zhang, MD, Gloria Zhang, MD
This CME activity was produced by the Cleveland Clinic Center for Continuing Education and
Cleveland Clinic's Pathology & Laboratory Medicine Institute.